| Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling S Vučković, R Dinani, EE Nollet, DWD Kuster, JW Buikema, ... Stem cell research & therapy 13 (1), 332, 2022 | 29 | 2022 |
| Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration EE Nollet, I Duursma, A Rozenbaum, M Eggelbusch, RCI Wüst, ... European heart journal 44 (13), 1170-1185, 2023 | 25 | 2023 |
| Unraveling the genotype‐phenotype relationship in hypertrophic cardiomyopathy: obesity‐related cardiac defects as a major disease modifier EE Nollet, BD Westenbrink, RA de Boer, DWD Kuster, J van der Velden Journal of the American Heart Association 9 (22), e018641, 2020 | 22 | 2020 |
| Large-scale contractility measurements reveal large atrioventricular and subtle interventricular differences in cultured unloaded rat cardiomyocytes EE Nollet, EM Manders, M Goebel, V Jansen, C Brockmann, J Osinga, ... Frontiers in physiology 11, 815, 2020 | 20 | 2020 |
| The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF C Withaar, LMG Meems, EE Nollet, EM Schouten, MA Schroeder, ... Basic to Translational Science 8 (10), 1298-1314, 2023 | 14 | 2023 |
| Equal force generation potential of trabecular and compact wall ventricular cardiomyocytes JW Faber, RCI Wüst, I Dierx, JA Hummelink, DWD Kuster, E Nollet, ... Iscience 25 (11), 2022 | 6 | 2022 |
| Western diet triggers cardiac dysfunction in heterozygous Mybpc3-targeted knock-in mice: a two-hit model of hypertrophic cardiomyopathy EE Nollet, S Algül, M Goebel, S Schlossarek, NN van der Wel, JJM Jans, ... Journal of Molecular and Cellular Cardiology Plus 6, 100050, 2023 | 5 | 2023 |
| SUMOylation does not affect cardiac troponin I stability but alters indirectly the development of force in response to Ca2+ B Fertig, J Ling, EE Nollet, S Dobi, T Busiau, K Ishikawa, K Yamada, ... The FEBS journal 289 (20), 6267-6285, 2022 | 3 | 2022 |
| A safety screening platform for individualized cardiotoxicity assessment V Schwach, RH Slaats, C Cofiño-Fabres, SA Ten Den, ... Iscience 27 (3), 2024 | 2 | 2024 |
| Differential growth rates, rather than compaction, determine left ventricular wall formation J Faber, R Wüst, I Dierx, J Hummelink, D Kuster, E Nollet, A Moorman, ... | 2 | 2021 |
| Generating reference values on mitochondrial respiration in permeabilized muscle fibers B Chabi, M Ost, P Gama-Perez, N Dahdah, H Lemieux, C Holody, C Rg, ... MitoFit Preprint Archives, 3p., 2019 | 2 | 2019 |
| “Disentangling” mitochondrial dysfunction in hypertrophic cardiomyopathy E Nollet, A Burdzina, RCI Wüst, M Michels, FW Asselbergs, N van der Wel, ... Journal of Molecular and Cellular Cardiology 173, S113-S115, 2022 | 1 | 2022 |
| Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With … EE Nollet, M Schuldt, V Sequeira, A Binek, TV Pham, SAC Schoonvelde, ... Circulation: Genomic and Precision Medicine, e004369, 2024 | | 2024 |
| Microtubule-induced restriction of nuclear deformability in hypertrophic cardiomyopathy I Duursma, EE Nollet, V Jansen, K Bedi, KB Margulies, NN Van Der Wel, ... Cardiovascular Research 120 (Supplement_1), cvae088. 124, 2024 | | 2024 |
| Metabolic perturbations as trigger and driver of disease in hypertrophic cardiomyopathy EE Nollet | | 2024 |
| The IRAK-M death domain: A tale of 3 surfaces B Gürkan, H Poelman, L Perverzeva, D Kruijswijk, AF de Vos, A Groenen, ... Frontiers in Molecular Biosciences 10, 1265455, 2024 | | 2024 |
| P400 Kbtbd13R408C-knockin mouse model elucidates mitochondrial pathomechanism in NEM6 R Baelde, AF Monteiro, E Nollet, R Galli, J Strom, J van der Velden, ... Neuromuscular Disorders 33, S123, 2023 | | 2023 |
| LINCing the nucleus: Nuclear abnormalities and chromatin alterations in hypertrophic cardiomyopathy I Duursma, E Nollet, K Bedi Jr, K Margulies, J van der Velden, T Kirby, ... Journal of Molecular and Cellular Cardiology 173, S70-S71, 2022 | | 2022 |
| The innate immune receptor NLRX1 protects against cardiac ischemia/reperfusion injury through RISK signaling, mPTP regulation and inhibition of mitochondrial activity Y Xiao, C Rudolphi, E Nollet, D Bakker, R Nederlof, Q Wang, ... Journal of Molecular and Cellular Cardiology 173, S8-S10, 2022 | | 2022 |
| Tracing triggers of cardiac remodelling and heart failure BO van Driel, EE Nollet Netherlands Heart Journal 29 (7), 357-358, 2021 | | 2021 |
